JMJD2D (human, recombinant)

JMJD2D (human, recombinant)
Artikelnummer
CAY10335
Verpackungseinheit
100 µg
Hersteller
Cayman Chemical

Verfügbarkeit: wird geladen...
Preis wird geladen...
Formulation: A solution in 50 mM HEPES, pH 7.4, with 150 mM sodium chloride and 20% glycerol

Purity: ≥75% estimated by SDS-PAGE

Shelf life (days): 180

Notes: Methylation of lysine residues in core histones plays a critical role in regulating gene expression.{18003} Jumonji domain containing 2D (JMJD2D) catalyzes the demethylation of di- and tri-methylated forms of histone H3 at lysine residue 9 (me 2/3), leading to transcriptional repression and activation, respectively.{18004} Like other JmjC protein hydroxylase family members, JMJD2D is an α-ketoglutarate-dependent Fe (II) oxygenase.{17970} Because of their implication in cancer cell growth, jumonji C domain-containing histone demethylase inhibitors may have the capacity to be anticancer agents.{18003}
Mehr Informationen
Artikelnummer CAY10335
Hersteller Cayman Chemical
Hersteller Artikelnummer 10335-100
Green Labware Nein
Verpackungseinheit 100 µg
Mengeneinheit STK
Produktinformation (PDF) Download
MSDS (PDF) Download